# Helix BioPharma Corp. (HBPCF)

> Healthcare · CA · Reports in CAD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/HBPCF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -2.37M | $ -2.21M | $ 358.9K | $ 14.68M |
| 2025 | $ 0 | $ -5.26M | $ -4.18M | $ 333.1K | $ 15.50M |
| 2024 | $ 0 | $ -9.44M | $ -5.33M | $ 0 | $ -90.0K |
| 2023 | $ 0 | $ -6.52M | $ -5.75M | $ 0 | $ -844.0K |
| 2022 | $ 0 | $ -7.04M | $ -6.98M | $ 2.47M | $ 319.0K |
| 2021 | $ 0 | $ -9.17M | $ -10.61M | $ 3.61M | $ -1.39M |
| 2020 | $ 0 | $ -10.78M | $ -12.96M | $ 159.0K | $ 2.39M |
| 2019 | $ 0 | $ -9.06M | $ -6.67M | $ 0 | $ -3.28M |
| 2018 | $ 0 | $ -10.62M | $ -9.33M | $ 0 | $ -1.53M |
| 2017 | $ 33.9K | $ -12.63M | $ -12.15M | $ 0 | $ -17.0K |
| 2016 | $ 0 | $ -12.36M | $ -11.38M | $ 0 | $ 3.16M |
| 2015 | $ 0 | $ -11.34M | $ -11.04M | $ 0 | $ 6.83M |
| 2014 | $ 0 | $ -11.45M | $ -10.15M | $ 0 | $ 6.81M |
| 2013 | $ 1.18M | $ -2.07M | $ -9.64M | $ 0 | $ 4.92M |
| 2012 | $ 5.77M | $ -23.61M | $ -20.16M | $ 0 | $ 6.22M |
| 2011 | $ 6.19M | $ -15.93M | $ -14.68M | $ 0 | $ 22.11M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.02 |
| Liabilities / Eq | 0.46 |
| Current Ratio | 0.45 |

## Other views

- [Metrics](https://sponda.capital/en/HBPCF.md)
- [Charts](https://sponda.capital/en/HBPCF/charts.md)
- [Compare](https://sponda.capital/en/HBPCF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.